The 2022 American Society of Hematology (ASH) Annual Assembly and Exposition was held from December 10 to 13 in New Orleans, Louisiana.
On this podcast, Christopher Flowers, MD, FASCO, discusses analysis offered on the assembly, together with new remedies for non-Hodgkin lymphoma and new fashions for predicting which sufferers could also be in danger for early illness development.
-
The FLIPI24 mannequin used age, hemoglobin ranges, white blood cell depend, lactate dehydrogenase ranges, and beta-2-microglobulin ranges to foretell which sufferers with follicular lymphoma could also be in danger for early illness development. [5:00]
-
The CCP-32 predictor used genomics to foretell which sufferers with diffuse giant B-cell lymphoma could also be in danger for early illness development. [6:11]
-
An replace on a kind of immunotherapy mentioned on the assembly known as bispecific antibodies, which deliver T cells into the tumor to assault the lymphoma cells. [7:11]
Dr. Flowers is the Chair of the Division of Lymphoma/Myeloma at The College of Texas MD Anderson Most cancers Middle and was appointed Division Head advert interim of Most cancers Medication in August 2020. Dr. Flowers can be the 2023 Most cancers.Web Affiliate Editor for Lymphoma.
Disclosure data for Dr. Flowers might be present in his biography linked to above.
Was this podcast helpful? Please subscribe, fee, and assessment Most cancers.Web Podcasts wherever you take heed to podcasts. This prerecorded podcast might be listened to on-line or downloaded to your pc. A transcript can be out there. For extra data, go to the Most cancers.Web podcast web page.
Most cancers.Web podcasts are edited for size and content material.
